Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-18 Sale | 2024-03-19 6:50 pm | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 4,018 | $1.3297 | $5,343 | 49,833 (Direct) | View |
| 2023-03-16 Sale | 2023-03-20 09:19 am | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 7,564 | $1.098 | $8,305 | 53,851 (Direct) | View |
| 2022-10-24 Sale | 2022-10-25 4:59 pm | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 4,757 | $12.07 | $57,431 | 61,415 (Direct) | View |
| 2022-03-16 Sale | 2022-03-17 5:00 pm | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 6,279 | $8.278 | $51,978 | 66,172 (Direct) | View |
| 2021-10-25 Sale | 2021-10-26 5:08 pm | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 2,377 | $12.25 | $29,118 | 72,451 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-01-04 5:11 pm | N/A 2034-01-01 | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 375,000 | $0 | 375,000 (Direct) | View |
| 2023-11-20 Option Award | 2023-11-22 7:07 pm | N/A 2033-11-19 | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 125,000 | $0 | 125,000 (Direct) | View |
| 2023-05-05 Disposition | 2023-05-09 4:25 pm | N/A 2029-03-25 | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 346,425 | $0 | 230,953 (Direct) | View |
| 2023-05-05 Option Award | 2023-05-09 4:25 pm | N/A 2029-03-25 | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 230,953 | $0 | 230,953 (Direct) | View |
| 2023-03-20 Option Award | 2023-03-22 5:21 pm | N/A 2033-03-19 | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 157,500 | $0 | 157,500 (Direct) | View |
| 2022-12-07 Option Award | 2022-12-09 5:20 pm | N/A 2032-12-06 | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 157,500 | $0 | 157,500 (Direct) | View |
| 2022-01-06 Option Award | 2022-01-10 4:11 pm | N/A 2032-01-05 | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 190,000 | $0 | 190,000 (Direct) | View |
| 2021-04-16 Option Award | 2021-04-20 6:07 pm | N/A 2031-04-16 | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 42,570 | $0 | 106,578 (Direct) | View |
Ownership | 2021-04-20 5:43 pm | N/A N/A | Gossamer Bio Inc. | GOSS | Peterson Caryn EVP, Regulatory Affairs | 0 | $0 | 324,015 (Direct) | View |